Disease 'reversal' startup launches with $3 billion and biotech vets
Teva Pharmaceutical agreed to pay $420 million to settle shareholder lawsuits alleging it hid a scheme to fix generic drug prices.
Source: statnews.com
Juno Biotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Juno Biotechnology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Juno Biotechnology Today - Breaking & Trending Today